News, Articles & Media

Cancer – The Cost of a Life

Friday 13th November 2015 – The New Zealand Herald investigates controversies in cancer testing and treatment and reports on the moving stories of people afflicted with cancer.  In the fifth and final part of this series, Herald health reporter Martin Johnston turns his attention to prostate cancer, and touches on Caldera’s diagnostic test.

“Caldera Health has … confirmed a panel of gene biomarkers for use in an affordable diagnostic test which … gives significantly better accuracy in terms of sensitivity and specificity than the PSA test,” the company says.

Read the full NZ Herald article here